Literature DB >> 10097152

Estrogen receptor (ER) modulators each induce distinct conformational changes in ER alpha and ER beta.

L A Paige1, D J Christensen, H Grøn, J D Norris, E B Gottlin, K M Padilla, C Y Chang, L M Ballas, P T Hamilton, D P McDonnell, D M Fowlkes.   

Abstract

Estrogen receptor (ER) modulators produce distinct tissue-specific biological effects, but within the confines of the established models of ER action it is difficult to understand why. Previous studies have suggested that there might be a relationship between ER structure and activity. Different ER modulators may induce conformational changes in the receptor that result in a specific biological activity. To investigate the possibility of modulator-specific conformational changes, we have applied affinity selection of peptides to identify binding surfaces that are exposed on the apo-ERs alpha and beta and on each receptor complexed with estradiol or 4-OH tamoxifen. These peptides are sensitive probes of receptor conformation. We show here that ER ligands, known to produce distinct biological effects, induce distinct conformational changes in the receptors, providing a strong correlation between ER conformation and biological activity. Furthermore, the ability of some of the peptides to discriminate between different ER alpha and ER beta ligand complexes suggests that the biological effects of ER agonists and antagonists acting through these receptors are likely to be different.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10097152      PMCID: PMC22409          DOI: 10.1073/pnas.96.7.3999

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Cloning of a novel receptor expressed in rat prostate and ovary.

Authors:  G G Kuiper; E Enmark; M Pelto-Huikko; S Nilsson; J A Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

2.  ER beta: identification and characterization of a novel human estrogen receptor.

Authors:  S Mosselman; J Polman; R Dijkema
Journal:  FEBS Lett       Date:  1996-08-19       Impact factor: 4.124

Review 3.  Steroid receptors and their associated proteins.

Authors:  D F Smith; D O Toft
Journal:  Mol Endocrinol       Date:  1993-01

Review 4.  Antiestrogens: future prospects.

Authors:  A Howell
Journal:  Oncology (Williston Park)       Date:  1997-02       Impact factor: 2.990

5.  Pharmacokinetics of 17 beta-dihydroequilin sulfate and 17 beta-dihydroequilin in normal postmenopausal women.

Authors:  B R Bhavnani; A Cecutti
Journal:  J Clin Endocrinol Metab       Date:  1994-01       Impact factor: 5.958

6.  Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens.

Authors:  D P McDonnell; D L Clemm; T Hermann; M E Goldman; J W Pike
Journal:  Mol Endocrinol       Date:  1995-06

7.  Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain.

Authors:  J M Beekman; G F Allan; S Y Tsai; M J Tsai; B W O'Malley
Journal:  Mol Endocrinol       Date:  1993-10

8.  Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial.

Authors:  R P Kedar; T H Bourne; T J Powles; W P Collins; S E Ashley; D O Cosgrove; S Campbell
Journal:  Lancet       Date:  1994-05-28       Impact factor: 79.321

9.  Effect of 17 alpha-dihydroequilin sulfate, a conjugated equine estrogen, and ethynylestradiol on atherosclerosis in cholesterol-fed rabbits.

Authors:  S J Adelman; A Chandrasekaran; J Jayo; R W St Clair
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-07       Impact factor: 8.311

10.  Sequence and characterization of a coactivator for the steroid hormone receptor superfamily.

Authors:  S A Oñate; S Y Tsai; M J Tsai; B W O'Malley
Journal:  Science       Date:  1995-11-24       Impact factor: 47.728

View more
  73 in total

1.  Rational discovery of novel nuclear hormone receptor antagonists.

Authors:  M Schapira; B M Raaka; H H Samuels; R Abagyan
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

Review 2.  Estrogen receptor and the SERM concept.

Authors:  G G Kuiper; G J van den Bemd; J P van Leeuwen
Journal:  J Endocrinol Invest       Date:  1999-09       Impact factor: 4.256

3.  Isotype-restricted corepressor recruitment: a constitutively closed helix 12 conformation in retinoic acid receptors beta and gamma interferes with corepressor recruitment and prevents transcriptional repression.

Authors:  Behnom Farboud; Herborg Hauksdottir; Yun Wu; Martin L Privalsky
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

Review 4.  Does loss of bile acid homeostasis make mice melancholy?

Authors:  David D Moore
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

Review 5.  Allosteric modulators of steroid hormone receptors: structural dynamics and gene regulation.

Authors:  Raj Kumar; Iain J McEwan
Journal:  Endocr Rev       Date:  2012-03-20       Impact factor: 19.871

6.  Distinct modulation of voltage-gated and ligand-gated Ca2+ currents by PPAR-gamma agonists in cultured hippocampal neurons.

Authors:  Tristano Pancani; Jeremiah T Phelps; James L Searcy; Michael W Kilgore; Kuey-Chu Chen; Nada M Porter; Olivier Thibault
Journal:  J Neurochem       Date:  2009-05-11       Impact factor: 5.372

7.  Research resource: Transcriptional profiling in a cellular model of breast cancer reveals functional and mechanistic differences between clinically relevant SERM and between SERM/estrogen complexes.

Authors:  Suzanne E Wardell; Dmitri Kazmin; Donald P McDonnell
Journal:  Mol Endocrinol       Date:  2012-05-08

8.  Flexible small molecular anti-estrogens with N,N-dialkylated-2,5-diethoxy-4-morpholinoaniline scaffold targets multiple estrogen receptor conformations.

Authors:  Bethany K Asare; Emmanuel Yawson; Rajendram V Rajnarayanan
Journal:  Cell Cycle       Date:  2017-07-19       Impact factor: 4.534

9.  27-hydroxycholesterol is an endogenous selective estrogen receptor modulator.

Authors:  Carolyn D DuSell; Michihisa Umetani; Philip W Shaul; David J Mangelsdorf; Donald P McDonnell
Journal:  Mol Endocrinol       Date:  2007-09-13

Review 10.  Estrogen receptor modulators and down regulators: optimal use in postmenopausal women with breast cancer.

Authors:  Christa K Baumann; Monica Castiglione-Gertsch
Journal:  Drugs       Date:  2007       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.